DRAM vs IBB: which is really different?
DRAM and IBB hold 0% of their weight in the same names. Roundhill Memory ETF and iShares Biotechnology ETF.
IBB costs 0.21 points a year less; DRAM is 2.4 times larger.
| DRAM | IBB | |
|---|---|---|
| Expense ratio | 0.65% | 0.44% |
| Net assets, as of Oct 8, 2026 | $24.2bn | $10.3bn |
| Total return, 1 year | not published | +36.1% |
| What it tracks | Memory and storage | Biotech |
| Holdings in common | 0% | |
| S&P 500, total return, since Apr 2, 2026 | +19.3% | |
| S&P 500, total return, 1 year | +17.3% | |
| Against the S&P 500, since Apr 2, 2026 | ahead by 86.7 pts | |
| Against the S&P 500, 1 year | ahead by 18.8 pts | |
| Below its all-time high | 29.1%, high on Jun 22, 2026 | |
Holdings in common uses holdings dated Jun 30, 2026 and Oct 8, 2026.
16% of DRAM's weight is in S&P 500 companies and 84% is outside the index. Holdings as of Jun 30, 2026.
40% of IBB's weight is in S&P 500 companies and 61% is outside the index. Holdings as of Oct 8, 2026.
A percentile among the 391 thematic ETFs with a holdings filing. All thematic ETFs ranked by it → How it is computed →
What they hold in common
By the books each fund has filed, DRAM and IBB hold 0% of their money in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and Oct 8, 2026.
half
0% in common
0% of the two portfolios are the same securities at the same weight.
Performance, window by window
| Total return | vs the S&P 500 | vs the Nasdaq-100 | ||||
|---|---|---|---|---|---|---|
| Window | DRAM | IBB | DRAM | IBB | DRAM | IBB |
| 3 months | −9.3% | +7.5% | −12.7 pts | +4.1 pts | −12.9 pts | +3.9 pts |
| 6 months | +76.3% | +21.9% | +61.2 pts | +6.8 pts | +53.1 pts | −1.3 pts |
| 1 year | not published | +36.1% | not published | +18.8 pts | not published | +12.5 pts |
| 3 years | not published | +69.1% | not published | −16.7 pts | not published | −38.2 pts |
| Since launch DRAM Apr 2026 · IBB Feb 2001 | +106.0% | +525.3% | +86.7 pts | −299.7 pts | +77.3 pts | −936.3 pts |
Source: ETFIQ. Open the live comparison on ETFIQ →
On the same fields
As of Oct 9, 2026. Source: ETFIQ.
DRAM in plain words
By weight, 16% of DRAM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 56% of the fund across 12 positions, as filed for Jun 30, 2026. Since it first traded on Apr 2, 2026 the fund returned +106.0% with distributions reinvested against +19.3% for the S&P 500, so a holder was ahead by 86.7 pts. It sits 29.1% below its all-time high of Jun 22, 2026.
IBB in plain words
By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 8, 2026. Over the year to Oct 9, 2026 the fund returned +36.1% with distributions reinvested against +17.3% for the S&P 500, so a holder was ahead by 18.8 pts.
Questions people ask
- Do DRAM and IBB hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
ETFIQ links to the documents behind every figure; a link is not an endorsement. A comparison is not a recommendation.
How this is computed
It is a position in a set, not a rating, and neither end of it is a recommendation.
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed.
Every figure is an ETFIQ calculation with distributions reinvested.
ETFIQ, DRAM against IBB, data as of Oct 9, 2026. https://etfiq.com/compare/themes/dram-vs-ibb
ETFIQ. (Oct 9, 2026). DRAM against IBB. Retrieved from https://etfiq.com/compare/themes/dram-vs-ibb
[DRAM against IBB (ETFIQ, Oct 9, 2026)](https://etfiq.com/compare/themes/dram-vs-ibb)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms.